Related Experiment Video
Updated: Mar 11, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Data-Driven Modeling for Precision Medicine in Pediatric Acute Liver Failure
Ruben Zamora1,2, Yoram Vodovotz1,2, Qi Mi1
1Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213.
Biomarkers for Pediatric Acute Liver Failure (PALF) are needed. Analyzing inflammatory mediator networks revealed that increased connectivity is linked to poor outcomes, potentially aiding in patient stratification.
Area of Science:
- Pediatric Hepatology
- Translational Medicine
- Systems Biology
Background:
- Early outcome biomarkers for Pediatric Acute Liver Failure (PALF) are currently lacking.
- This absence complicates critical medical and liver transplant decisions for affected children.
- Understanding dynamic inflammatory processes may offer insights into PALF prognosis.
Purpose of the Study:
- To define dynamic interactions among circulating inflammatory mediators in PALF patients.
- To identify patterns associated with different patient outcomes (spontaneous survival, non-survival, liver transplant).
- To explore the potential of these interactions as predictive biomarkers.
Main Methods:
- Serum samples from 101 PALF participants were collected within 7 days of enrollment.
- 27 inflammatory mediators were assayed.
- Data-driven algorithms, including Dynamic Bayesian Network inference, were used to analyze mediator interrelations and network dynamics over time.
Main Results:
- A common network motif with HMGB1 as a central node was identified across all patient subgroups.
- Dynamic network connectivity differed between spontaneous survivors (S) and liver transplant (LTx) patients compared to non-survivors (NS).
- A Dynamic Robustness Index effectively differentiated between S, NS, and LTx subgroups, with higher interconnectedness observed in NS patients that increased over time.
Conclusions:
- Increasing inflammatory network connectivity in PALF is associated with non-survival.
- Dynamic network analysis of inflammatory mediators shows promise for stratifying PALF patient outcomes.
- These findings may lead to improved clinical decision-making and patient management in PALF.
More Related Videos
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmacokinetics in Pediatric Patients: Drug Metabolism